Synapse

← Antisense Research and Development

Papers in Antisense Research and Development

Page 2 · newest first

  1. Systemic Administration of a Phosphorothioate Oligonucleotide with a Sequence Complementary to p53 for Acute Myelogenous Leukemia and Myelodysplastic Syndrome: Initial Results of a Phase I TrialAntisense Research and Development · 1993
  2. Computer-Aided Search for Effective Antisense RNA Target Sequences of the Human Immunodeficiency Virus Type 1Antisense Research and Development · 1993
  3. Targeting of Antisense DNA: Comparison of Activity of Anti-Rabbit β-Globin Oligodeoxyribonucleoside Phosphorothioates with Computer Predictions of mRNA FoldingAntisense Research and Development · 1993
  4. Oligonucleotide—Poly-L-ornithine Conjugates: Binding to Complementary DNA and RNAAntisense Research and Development · 1993
  5. Antisense Sequences of 20-kDa Homologous Restriction Factor (HRF20) Are Found in C9 and the C8 β Chain of Homologous ComplementAntisense Research and Development · 1993
  6. Internalization of Oligodeoxyribonucleotides by Vibrio parahaemolyticusAntisense Research and Development · 1993
  7. Investigations of Antisense Oligonucleotides Targeted Against bcl-2 RNAsAntisense Research and Development · 1993
  8. Sequence-Specific DNA Damage Using Iodine-125-Labeled Antisense OligonucleotidesAntisense Research and Development · 1993
  9. Simultaneous Inhibition of Two Tomato Fruit Cell Wall Hydrolases, Pectinmethylesterase and Polygalacturonase, with Antisense Gene ConstructsAntisense Research and Development · 1993
  10. Co-Suppression of Dictyostelium discoideum Myosin II Heavy-Chain Gene Expression by a Sense Orientation TranscriptAntisense Research and Development · 1993
  11. A Sense Phosphorothioate Oligonucleotide Directed to the Initiation Codon of Transcription Factor NF-κ-B Causes Sequence-Specific Immune StimulationAntisense Research and Development · 1993
  12. Phosphorothioate Oligodeoxynucleotides Bind to the Third Variable Loop Domain (v3) of Human Immunodeficiency Virus Type 1 gp120Antisense Research and Development · 1993
  13. Pharmacokinetics, Biodistribution, and Stability of Capped Oligodeoxynucleotide Phosphorothioates in MiceAntisense Research and Development · 1993
  14. Effect on Embryos of Injection of Phosphorothioate-Modified Oligonucleotides into Pregnant MiceAntisense Research and Development · 1993
  15. Investigations of Oligodeoxyinosine for Triple Helix FormationAntisense Research and Development · 1993
  16. Regulatory Considerations for Evaluating the Pharmacology and Toxicology of Antisense DrugsAntisense Research and Development · 1993
  17. Stimulation of Calcium Influx in HL60 Cells by Cholesteryl-Modified Homopolymer OligodeoxynucleotidesAntisense Research and Development · 1992
  18. The Use of Antisense Oligonucleotides to Establish Autocrine Angiotensin Growth Effects in Human Neuroblastoma and Mesangial CellsAntisense Research and Development · 1992
  19. Characterization and Minimization of Cellular Autofluorescence in the Study of Oligonucleotide Uptake Using Confocal MicroscopyAntisense Research and Development · 1992
  20. Liposomes as a Drug Delivery System for Antisense OligonucleotidesAntisense Research and Development · 1992
  21. Antisense Effect of Oligodeoxynucleotides with Inverted Terminal Internucleotidic Linkages: A Minimal Modification Protecting against Nucleolytic DegradationAntisense Research and Development · 1992
  22. Injection of Antisense RNA Specific for E-Cadherin Demonstrates That E-Cadherin Facilitates Compaction, the First Differentiative Step of the Mammalian EmbryoAntisense Research and Development · 1992
  23. Sequence-Specific Cleavage of Single-Stranded DNA by Oligonucleotides Conjugated to BleomycinAntisense Research and Development · 1992
  24. Inhibition of Human Immunodeficiency Virus-1 Proliferation by Liposome-Encapsulated Sense DNA to the 5′ TAT Splice Acceptor SiteAntisense Research and Development · 1992
  25. Cellular Uptake and Subcellular Distribution of Phosphorothioate Oligonucleotides into Cultured CellsAntisense Research and Development · 1992
  26. Incorporation of Radiophosphorus from Labeled Oligodeoxynucleotides into RNA of Mycoplasma in Cell CulturesAntisense Research and Development · 1992
  27. Inhibition of Murine Leukemia Viruses by Nuclease-Resistant α-OligonucleotidesAntisense Research and Development · 1992
  28. Cell Membranes as Barriers for Antisense ConstructionsAntisense Research and Development · 1992
  29. Poly(L-Lysine)-Conjugated Oligonucleotides Promote Sequence-Specific Inhibition of Acute HIV-1 InfectionAntisense Research and Development · 1992
  30. Analysis of Oligonucleotide Binding, Internalization, and Intracellular Trafficking Utilizing a Novel Radiolabeled CrosslinkerAntisense Research and Development · 1992
  31. Antisense Oligonucleotide Inhibition of Bovine Leukemia Virus tax Expression in a Cell-Free SystemAntisense Research and Development · 1992
  32. Translation Inhibition by Phosphorothioate Oligodeoxynucleotides in Cell-Free SystemsAntisense Research and Development · 1992
  33. Lipofectin Enhances Cellular Uptake of Antisense DNA While Inhibiting Tumor Cell GrowthAntisense Research and Development · 1992
  34. Ribozyme-Mediated Cleavage of an HIV-1 gag RNA: The Effects of Nontargeted Sequences and Secondary Structure on Ribozyme Cleavage ActivityAntisense Research and Development · 1991
  35. Substrate Specificity and Kinetics of Degradation of Antisense Oligonucleotides by a 3′ Exonuclease in PlasmaAntisense Research and Development · 1991
  36. Reversible Transformation by v- sis: A Model Cell Line for Analysis of Transformation by Antisense MethodsAntisense Research and Development · 1991
  37. Uptake of Oligodeoxyribonucleotides by Lymphoid Cells Is Heterogeneous and InducibleAntisense Research and Development · 1991
  38. Exploring the Use of Antisense, Enzymatic RNA Molecules (Ribozymes) as Therapeutic AgentsAntisense Research and Development · 1991
  39. Pathways of Degradation and Mechanism of Action of Antisense Oligonucleotides in Xenopus laevis EmbryosAntisense Research and Development · 1991
  40. Recognition and Photo-Induced Cleavage and Cross-Linking of Nucleic Acids by Oligonucleotides Covalently Linked to EllipticineAntisense Research and Development · 1991
  41. Non–Sequence-Specific Inhibition of Transferrin Receptor Expression in HL-60 Leukemia Cells by Phosphorothioate OligodeoxynucleotidesAntisense Research and Development · 1991
  42. Photoactivatable Antisense DNA: Suppression of Ampicillin Resistance in Normally Resistant Escherichia coliAntisense Research and Development · 1991
  43. Informational Drugs: A New Concept in PharmacologyAntisense Research and Development · 1991
  44. In Vivo Modulation of N- myc Expression by Continuous Perfusion with an Antisense OligonucleotideAntisense Research and Development · 1991
  45. DNA Triple-Helix Formation at Physiologic pH and TemperatureAntisense Research and Development · 1991
  46. Dominant Positive and Negative Selection Using a Hygromycin Phosphotransferase–Thymidine Kinase Fusion GeneAntisense Research and Development · 1991
  47. Antisense RNA Inhibition of Expression of a Pair of Tandemly Repeated Genes Results in a Delay in Cell–Cell Adhesion in DictyosteliumAntisense Research and Development · 1991
  48. The Clearance and Degradation of Oligodeoxynucleotides Following Intravenous Injection into RabbitsAntisense Research and Development · 1991
  49. Antibacterial Activity and Inhibition of Protein Synthesis in Escherichia coli by Antisense DNA AnalogsAntisense Research and Development · 1991
  50. Oligonucleotide-Directed DNA Triple-Helix Formation: An Approach to Artificial Repressors?Antisense Research and Development · 1991